Clinical Trial Update: Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety study update for SCT800 in on-demand treatment of Hemophilia A; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• SCT800

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Hemophilia A | Phase 3 | Status: UNKNOWN